<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/546582A9-ECD9-4857-ACDF-772746AC8508"><gtr:id>546582A9-ECD9-4857-ACDF-772746AC8508</gtr:id><gtr:name>Department for Environment, Food and Rural Affairs (Defra)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/A43B383E-7893-4709-98F4-D514F5F628F9"><gtr:id>A43B383E-7893-4709-98F4-D514F5F628F9</gtr:id><gtr:name>FAO/IAEA Agriculture and Biotechnology Laboratories</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/59EE6C94-CB2C-4AB3-9A0B-EAAF5A6550CD"><gtr:id>59EE6C94-CB2C-4AB3-9A0B-EAAF5A6550CD</gtr:id><gtr:name>The Pirbright Institute</gtr:name><gtr:department>UNLISTED</gtr:department><gtr:address><gtr:line1>Ash Road</gtr:line1><gtr:line2>Pirbright</gtr:line2><gtr:line4>Woking</gtr:line4><gtr:line5>Surrrey</gtr:line5><gtr:postCode>GU24 0NF</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/59EE6C94-CB2C-4AB3-9A0B-EAAF5A6550CD"><gtr:id>59EE6C94-CB2C-4AB3-9A0B-EAAF5A6550CD</gtr:id><gtr:name>The Pirbright Institute</gtr:name><gtr:address><gtr:line1>Ash Road</gtr:line1><gtr:line2>Pirbright</gtr:line2><gtr:line4>Woking</gtr:line4><gtr:line5>Surrrey</gtr:line5><gtr:postCode>GU24 0NF</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/1E58895D-AC7A-47A8-A238-60C71608E4DD"><gtr:id>1E58895D-AC7A-47A8-A238-60C71608E4DD</gtr:id><gtr:name>Scottish Executive Env and Rural Affairs</gtr:name><gtr:address><gtr:line1>Room 440</gtr:line1><gtr:line2>Pentland House</gtr:line2><gtr:line3>47 Robb's Loan</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH14 1TY</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>CO_FUNDER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/8168D0C6-0D11-4346-8107-E5D172AFD438"><gtr:id>8168D0C6-0D11-4346-8107-E5D172AFD438</gtr:id><gtr:name>Dept for International Development DFID</gtr:name><gtr:address><gtr:line1>1 Palace Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SW1E 5HE</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>CO_FUNDER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/546582A9-ECD9-4857-ACDF-772746AC8508"><gtr:id>546582A9-ECD9-4857-ACDF-772746AC8508</gtr:id><gtr:name>Department for Environment, Food and Rural Affairs (Defra)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/A43B383E-7893-4709-98F4-D514F5F628F9"><gtr:id>A43B383E-7893-4709-98F4-D514F5F628F9</gtr:id><gtr:name>FAO/IAEA Agriculture and Biotechnology Laboratories</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/EC70C3DA-A04C-4C69-8B54-0386B4C2887D"><gtr:id>EC70C3DA-A04C-4C69-8B54-0386B4C2887D</gtr:id><gtr:name>Ministry of Agri MAAIF</gtr:name><gtr:address><gtr:line1>PO Box 102</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Uganda</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/66A1D773-B5EC-42B7-96C9-5F57EFFF97C3"><gtr:id>66A1D773-B5EC-42B7-96C9-5F57EFFF97C3</gtr:id><gtr:firstName>David</gtr:firstName><gtr:otherNames>James</gtr:otherNames><gtr:surname>Paton</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/EDAB4FFF-7507-4037-9884-BDFCB07D19B7"><gtr:id>EDAB4FFF-7507-4037-9884-BDFCB07D19B7</gtr:id><gtr:firstName>Satya</gtr:firstName><gtr:surname>Parida</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/4EC4D37D-C2D2-4891-A21C-3AFCFCCDD1F1"><gtr:id>4EC4D37D-C2D2-4891-A21C-3AFCFCCDD1F1</gtr:id><gtr:firstName>Nagendrakumar</gtr:firstName><gtr:otherNames>Balasubramanian</gtr:otherNames><gtr:surname>Singanallur</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/9C5B6126-27A8-43DD-A3A6-C4E55190175A"><gtr:id>9C5B6126-27A8-43DD-A3A6-C4E55190175A</gtr:id><gtr:firstName>Madhuchhanda</gtr:firstName><gtr:surname>Mahapatra</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/AE069D7A-5946-43C0-885A-688511033440"><gtr:id>AE069D7A-5946-43C0-885A-688511033440</gtr:id><gtr:firstName>Villuppanoor</gtr:firstName><gtr:otherNames>Alwar</gtr:otherNames><gtr:surname>Srinivasan</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/CE146019-4C9C-4A7B-9F36-465109DCCA14"><gtr:id>CE146019-4C9C-4A7B-9F36-465109DCCA14</gtr:id><gtr:firstName>Jayne</gtr:firstName><gtr:surname>Hope</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/826D31C4-6840-4F4A-9046-11E48AF7BCEC"><gtr:id>826D31C4-6840-4F4A-9046-11E48AF7BCEC</gtr:id><gtr:firstName>Francois</gtr:firstName><gtr:otherNames>Frederick</gtr:otherNames><gtr:surname>Maree</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/84244E8E-417D-4273-9C72-5E13832D5D17"><gtr:id>84244E8E-417D-4273-9C72-5E13832D5D17</gtr:id><gtr:firstName>Daniel</gtr:firstName><gtr:surname>Haydon</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/EE5587C2-10B1-48E6-B4DA-4A241C70C3DE"><gtr:id>EE5587C2-10B1-48E6-B4DA-4A241C70C3DE</gtr:id><gtr:firstName>Madhanmohan</gtr:firstName><gtr:surname>Muthukrishnan</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/5DC8742C-F283-44E9-9393-25DE98BDE551"><gtr:id>5DC8742C-F283-44E9-9393-25DE98BDE551</gtr:id><gtr:firstName>Geraldine</gtr:firstName><gtr:surname>Taylor</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/0CF2FCF1-E537-4CB3-81B6-7A969F3BEF45"><gtr:id>0CF2FCF1-E537-4CB3-81B6-7A969F3BEF45</gtr:id><gtr:firstName>Richard</gtr:firstName><gtr:surname>Reeve</gtr:surname><gtr:roles><gtr:role><gtr:name>RESEARCHER_COI</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=BB%2FH009175%2F1"><gtr:id>90E3EA51-0F9B-4432-99A2-A39E7D4B611E</gtr:id><gtr:title>Improving the quality of FMD vaccines by understanding the correlation of vaccine-induced protection with humoral and cellular immune responses</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/H009175/1</gtr:grantReference><gtr:abstractText>Foot-and-mouth disease (FMD) is a highly contagious disease of cloven-hoofed domestic and wild animals with a global distribution. It remains widespread in developing countries including those of sub-Saharan Africa and South Asia, where it seriously affects livestock productivity through weight loss, decrease in milk yield and loss of draught power. This damage is greatly exacerbated by the cost of control measures and the restrictions imposed on the trade of animals and their products within and from FMD-infected areas reducing output and investment in agriculture. FMD can be controlled by restricting animal movements, by slaughtering affected animals and by vaccination; the latter being used continuously in countries where the disease is common and as an emergency measure if disease is newly introduced. FMD virus (FMDV) is in the genus Aphthovirus and the family Picornaviridae. It exists as 7 immunologically distinct types (serotypes) with little or no cross-protection between them. New variant viruses emerge periodically and may be poorly controlled by immunity to existing subtypes of the same serotype. Consequently, vaccine strain requirements differ according to the types and subtypes of virus prevailing in or threatening different regions and vaccines have to be selected with care. To inform this selection process requires collection of circulating viruses and determination of their match to existing vaccine strains, followed where necessary by development of new vaccine strains. Vaccination using killed virus grown in large cell cultures is critical to FMD control in developing countries where the weakness of veterinary services and lack of animal movement controls preclude reliance on other measures. However, current vaccines provide only short-lived protection (~6 months) that is serotype-specific and sometimes strain-specific. Each batch of the vaccine also needs to be tested in animals with live FMDV challenge to ensure quality and potency. This requires costly high containment facilities that may be unavailable or pose a risk of virus escape. These challenges to vaccine-mediated FMD control programmes have led to the virtual abandonment of attempts to establish FMD surveillance and control programmes in many parts of the developing world and to a lack of vaccine strains tailored for some regions. This project seeks to overcome the above-mentioned constraints to developing effective vaccine-based control strategies in developing countries. This will be achieved by three complementary initiatives. Firstly, vaccine strains will be selected that are appropriate for Eastern Africa, and associated to this work, the methodology for selecting vaccine strains will be simplified, bringing benefits to other regions as well. Secondly, novel adjuvants that have been identified for use in human vaccine formulations and that could enhance the potency and duration of vaccine-induced protection will be evaluated for FMD control. Thirdly, new methodology will be developed and validated to enable batch testing of FMD vaccines based on analysis of the immune responses of vaccinated animals, without a requirement to challenge these animals with virulent live virus. The combination of the use of novel adjuvants to increase the potency and duration of protection, better vaccine matching to induce more targeted coverage of circulating strains, and the increased use of in vitro assays to reduce the costs of vaccine testing could provide a significant breakthrough in the cost-effectiveness of vaccine use and hence FMD control in sub-Saharan Africa and South Asia.</gtr:abstractText><gtr:technicalSummary>Foot-and-mouth disease virus (FMDV) causes a contagious and devastating disease of domestic animals (FMD) and vaccination is of paramount importance for its control in developing countries. However, vaccine-mediated protection is short-lived, making vaccination policies hard to afford. Current FMD vaccines are serotype specific and may fail to protect fully against subtypes. Consequently, vaccine strains have to be selected, based on cumbersome and difficult to standardise serological matching methods. Batch testing of vaccine efficacy is essential to guarantee the quality of vaccines but current potency tests require costly and risky challenges of vaccinated animals with virulent live virus. In order to improve vaccine selection, the project will target East Africa, where there is a diversity of circulating viruses and lack of tailored vaccine strains. This deficit will be overcome by serological characterisation of field isolates and vaccine strains. The genes encoding the virion proteins of these viruses will be sequenced to determine genetic determinants of their antigenic phenotypes and to develop a sequence-based vaccine selection method to replace the current serological approaches. This will have world-wide application to vaccine strain selection and to design of more broadly cross-reactive vaccines. To avoid reliance on live virus animal challenges in vaccine testing, the project will develop a mathematical model for predicting protection from the immune responses of vaccinated animals, combining serological data with novel measures of cell-mediated immunity. This technology will be transferred to African and Asian partners. It is hypothesised that the efficacy and duration of immunity of FMD vaccines can be improved by strengthening both the Th1 and Th2 responses and that this should be possible by introduction of novel TLR agonists that will be analysed for this use, thereby making FMD vaccines more affordable in developing countries.</gtr:technicalSummary><gtr:potentialImpactText>Foot-and-mouth disease is an important cause of loss of productivity and due to its rapid spread is considered to be the single most important constraint to international trade in animals and animal products. It is very difficult for small-scale livestock producers to take unilateral actions to protect against the effects of FMD, since the virus spreads readily from their neighbours and prevents them from marketing their products abroad. This in turn leads to a reduction in inward investment to improve productivity and output. Furthermore, since the seriousness of the losses incurred during FMD outbreaks is directly related to the productivity of the animals, it makes it difficult for livestock keepers to move beyond subsistence agriculture. Better FMD vaccines are the key to improved FMD control in developing countries. They can be used by individual farmers to protect their animals from direct losses, and form the basis for national/regional control schemes to reduce and eventually curtail virus circulation. There is a growing body of opinion that access to international markets for certain animal products such as deboned beef need not be dependent on achieving national control of FMD. Instead, FMD-free compartments could be established from which these commodities could be safely exported, providing that there are adequate quarantine facilities and crucially that appropriate and efficacious vaccines are available. This project has specifically targeted a number of practical measures that would make a significant impact on the availability of appropriate vaccines and thereby encourage the development of new vaccine-based FMD control programmes to help developing countries. In parts of East Africa, there are regions where profitability of livestock production could be significantly improved if FMD control were better. Therefore, the project has targeted the selection of new vaccine strains that would be tailored to the needs of this region. These local benefits could be realised within or shortly after the life of the project, as there are regional (as well as distant) vaccine manufacturers in Botswana and Kenya that could rapidly introduce these new vaccine strains. The project also addresses the wider need to develop simplified vaccine selection techniques that could be applied, also in the short term, to improve availability of suitable vaccine strains. The project also looks to introduce vaccines with greater potency and duration of protection, developments that would significantly improve the cost-benefit of vaccine-based control schemes in developing countries. Since the approach is based on novel adjuvants and retains the existing procedure for manufacturing vaccine antigens, it is envisaged that these developments could lead to new registered products in a relatively short timescale - perhaps 3-5 years after completion of the project. Finally, long experience of vaccine-based FMD control in South America made clear that without proper batch testing, it was impossible to guarantee the quality of vaccines on the market and without this, confidence in vaccine-based control was soon under-mined. The project therefore provides a novel approach to improving vaccine efficacy testing that could also be introduced shortly after the end of the project's life. Although targeted at problems for the developing world for FMD control, some of the outputs of this project would also be expected to contribute to FMD control in the developed world, where experience with the massive culling of animals required to control FMD in UK in 2001 has led to a desire to place greater emphasis on vaccination as a means of FMD control.</gtr:potentialImpactText><gtr:fund><gtr:end>2015-05-16</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2011-05-17</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>872619</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>FAO/IAEA Agriculture and Biotechnology Laboratories</gtr:collaboratingOrganisation><gtr:country>Austria, Republic of</gtr:country><gtr:description>collaboration/parners</gtr:description><gtr:id>91F6EE41-1F04-41EC-A835-5AC13F065FF1</gtr:id><gtr:impact>Joint Publications</gtr:impact><gtr:partnerContribution>Joint application</gtr:partnerContribution><gtr:piContribution>Joint application</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>The Jenner Institute</gtr:department><gtr:description>collaboration/parners</gtr:description><gtr:id>4D7909CC-0AE2-4786-9C11-7293AF30298A</gtr:id><gtr:impact>Joint Publications</gtr:impact><gtr:partnerContribution>Joint application</gtr:partnerContribution><gtr:piContribution>Joint application</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Department For Environment, Food And Rural Affairs (DEFRA)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Animal Health And Veterinary Laboratories Agency (AHVLA)</gtr:department><gtr:description>collaboration/parners</gtr:description><gtr:id>47880BB2-B079-463F-A7D6-89296FD9F38B</gtr:id><gtr:impact>Joint Publications</gtr:impact><gtr:partnerContribution>Joint application</gtr:partnerContribution><gtr:piContribution>Joint application</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>2 FMD workshop in Arusha, Tanzania</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D3E71919-079D-4FF5-BBC6-7DA68E5E154C</gtr:id><gtr:impact>FMD diagnosis, sample collection and control by vaccination had been discussed</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2013,2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>201000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Improving the duration of immunity for FMD vaccine</gtr:description><gtr:end>2017-05-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>BADE94ED-AE00-49E6-81E0-4F0783606CA5</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2016-05-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>The project demonstrated that the current A serotype FMD vaccines are not protective against circulating viruses where as our putative vaccine strains selected for Eastern Africa provide broad cross protection. The Merial is interested to adapt the selected vaccine strains as new vaccines.
Similarly the adjuvant selected for the FMD vaccine showed both enhanced potency and immunogenecity using half or less than half the amount of antigen. Therefore industry ( Indian Immunologicals and Biovet Brazil) is also keen to test this adjuvant for the longer duration immunity.</gtr:description><gtr:id>A44D01BA-4639-4B47-AF1A-CA9DDD67EA91</gtr:id><gtr:impactTypes><gtr:impactType>Societal,Economic</gtr:impactType></gtr:impactTypes><gtr:sector>Agriculture, Food and Drink,Education,Healthcare,Manufacturing, including Industrial Biotechology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>1. Current A serotype FMD vaccines used in Eastern Africa do not provide protection against circulating viruses.
2. We have selected new vaccine strains that provide broad cross protection for almost all recently circulating viruses.
3. We have demonstrated a potent TLR adjuvant that help to stimulate FMD vaccine to provide both humoral and cell-mediated responses (CD4+ and CD8+) responses.
4. The project had demonstrated a vaccine induced correlation protection with neutralising antibody and Interferon-Y responses.</gtr:description><gtr:exploitationPathways>An Industry is taking forward the new vaccine strains and adjuvant selected in the projects to formulate a new vaccine for use in East Africa.</gtr:exploitationPathways><gtr:id>F467D628-23FE-40CE-864A-838F73D19ACC</gtr:id><gtr:sectors><gtr:sector>Agriculture, Food and Drink,Communities and Social Services/Policy,Creative Economy,Education,Healthcare,Government, Democracy and Justice,Manufacturing, including Industrial Biotechology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/67C96A0B-8E58-486C-9F26-C37509CADB7B"><gtr:id>67C96A0B-8E58-486C-9F26-C37509CADB7B</gtr:id><gtr:title>Peste des petits ruminants infection among cattle and wildlife in northern Tanzania.</gtr:title><gtr:parentPublicationTitle>Emerging infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9d6ee4953a1386ff450c145c67fdb307"><gtr:id>9d6ee4953a1386ff450c145c67fdb307</gtr:id><gtr:otherNames>Lembo T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1080-6040</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/87EE4328-D824-4FF1-8CF5-9AE51223C2B9"><gtr:id>87EE4328-D824-4FF1-8CF5-9AE51223C2B9</gtr:id><gtr:title>Antigenic and genetic comparison of foot-and-mouth disease virus serotype O Indian vaccine strain, O/IND/R2/75 against currently circulating viruses.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/27d495066860a08816b32799bb097075"><gtr:id>27d495066860a08816b32799bb097075</gtr:id><gtr:otherNames>Mahapatra M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/43C1B1C7-D419-4B1E-8C7F-F4B2F7F196AC"><gtr:id>43C1B1C7-D419-4B1E-8C7F-F4B2F7F196AC</gtr:id><gtr:title>Tracking the Antigenic Evolution of Foot-and-Mouth Disease Virus.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/84266c39519fdec9b263e1ab8c983276"><gtr:id>84266c39519fdec9b263e1ab8c983276</gtr:id><gtr:otherNames>Reeve R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FC1AAAA0-F68C-4802-A970-57F3D91B6CF9"><gtr:id>FC1AAAA0-F68C-4802-A970-57F3D91B6CF9</gtr:id><gtr:title>Interferon-? induced by in vitro re-stimulation of CD4+ T-cells correlates with in vivo FMD vaccine induced protection of cattle against disease and persistent infection.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/506742cb5e64e379e0d4ca2d134c00b4"><gtr:id>506742cb5e64e379e0d4ca2d134c00b4</gtr:id><gtr:otherNames>Oh Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8A9651BA-B5AA-4586-BF13-A5C5DD2CC8F0"><gtr:id>8A9651BA-B5AA-4586-BF13-A5C5DD2CC8F0</gtr:id><gtr:title>Adenovirus Expressing Human Interferon Inhibits Replication of Foot and Mouth Disease Virus and Reduces Fatal Rate in Mice</gtr:title><gtr:parentPublicationTitle>Journal of Bacteriology and Virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/83255e743474340406c4ec075c0ea7dc"><gtr:id>83255e743474340406c4ec075c0ea7dc</gtr:id><gtr:otherNames>Chu J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2F0A6D0C-9B8E-40ED-8FA3-4815EC2F4AF0"><gtr:id>2F0A6D0C-9B8E-40ED-8FA3-4815EC2F4AF0</gtr:id><gtr:title>Novel antibody binding determinants on the capsid surface of serotype O foot-and-mouth disease virus.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5fc3e6e8a07bbe6344d0ecdbec0580e8"><gtr:id>5fc3e6e8a07bbe6344d0ecdbec0580e8</gtr:id><gtr:otherNames>Asfor AS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2A3BE85E-A1CB-48B0-A70F-2C5D8DC716B0"><gtr:id>2A3BE85E-A1CB-48B0-A70F-2C5D8DC716B0</gtr:id><gtr:title>Emergence of antigenic variants within serotype A FMDV in the Middle East with antigenically critical amino acid substitutions.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/27d495066860a08816b32799bb097075"><gtr:id>27d495066860a08816b32799bb097075</gtr:id><gtr:otherNames>Mahapatra M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/63050459-EDCF-4071-9F07-FC770894A4F2"><gtr:id>63050459-EDCF-4071-9F07-FC770894A4F2</gtr:id><gtr:title>Genetic basis of antigenic variation in foot-and-mouth disease serotype A viruses from the Middle East.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f509c7b8bc65837d8a2ba7024d7145cb"><gtr:id>f509c7b8bc65837d8a2ba7024d7145cb</gtr:id><gtr:otherNames>Upadhyaya S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/10D3FCB9-FF3A-4F73-898C-E6444FD13E26"><gtr:id>10D3FCB9-FF3A-4F73-898C-E6444FD13E26</gtr:id><gtr:title>Evolutionary non-linear modelling for selecting vaccines against antigenically variable viruses.</gtr:title><gtr:parentPublicationTitle>Bioinformatics (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f03a178310c84d1f0d8aa9131e017a31"><gtr:id>f03a178310c84d1f0d8aa9131e017a31</gtr:id><gtr:otherNames>Rahman T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1367-4803</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/387FE87F-644A-48D6-A518-7CBB902C66DB"><gtr:id>387FE87F-644A-48D6-A518-7CBB902C66DB</gtr:id><gtr:title>Prediction and characterization of novel epitopes of serotype A foot-and-mouth disease viruses circulating in East Africa using site-directed mutagenesis.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b114cba5cc670a5008fb5728e9f70942"><gtr:id>b114cba5cc670a5008fb5728e9f70942</gtr:id><gtr:otherNames>Bari FD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5F2D31E5-44F8-4490-8171-71AE63FB86CC"><gtr:id>5F2D31E5-44F8-4490-8171-71AE63FB86CC</gtr:id><gtr:title>Emergence of PPR and its threat to Europe.</gtr:title><gtr:parentPublicationTitle>Small ruminant research : the journal of the International Goat Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1a8dacccded08458ce367dbbff937e65"><gtr:id>1a8dacccded08458ce367dbbff937e65</gtr:id><gtr:otherNames>Parida S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0921-4488</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/371A704D-44E2-4565-A57E-9D887D6AE3CF"><gtr:id>371A704D-44E2-4565-A57E-9D887D6AE3CF</gtr:id><gtr:title>Identification of Low- and High-Impact Hemagglutinin Amino Acid Substitutions That Drive Antigenic Drift of Influenza A(H1N1) Viruses.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/64b6d3888aa253092661ec6f881fc031"><gtr:id>64b6d3888aa253092661ec6f881fc031</gtr:id><gtr:otherNames>Harvey WT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/58DF8BC7-DBC0-4F97-9EBE-A8389CEC4FD0"><gtr:id>58DF8BC7-DBC0-4F97-9EBE-A8389CEC4FD0</gtr:id><gtr:title>Antigenic variation of foot-and-mouth disease virus serotype A.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4e8693fb953a1a5ec7838c7ec6e8b8f3"><gtr:id>4e8693fb953a1a5ec7838c7ec6e8b8f3</gtr:id><gtr:otherNames>Ludi AB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/31ADCDC4-225E-4703-AEBF-44963B43E05A"><gtr:id>31ADCDC4-225E-4703-AEBF-44963B43E05A</gtr:id><gtr:title>A DNA vaccination regime including protein boost and electroporation protects cattle against foot-and-mouth disease.</gtr:title><gtr:parentPublicationTitle>Antiviral research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/974dc0a341f43804f4cf1b808e6a10da"><gtr:id>974dc0a341f43804f4cf1b808e6a10da</gtr:id><gtr:otherNames>Fowler V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0166-3542</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7AD72B73-73D2-4A9C-9CD3-F86E3E7299DC"><gtr:id>7AD72B73-73D2-4A9C-9CD3-F86E3E7299DC</gtr:id><gtr:title>Genetic and antigenic characterisation of serotype A FMD viruses from East Africa to select new vaccine strains.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b114cba5cc670a5008fb5728e9f70942"><gtr:id>b114cba5cc670a5008fb5728e9f70942</gtr:id><gtr:otherNames>Bari FD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/H009175/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>